Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications

Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications (2022)

Authors:
USP affiliated authors: CUNHA, FERNANDO DE QUEIROZ - FMRP ; WANDERLEY, CARLOS WAGNER DE SOUZA - FMRP
Unidade: FMRP
DOI: 10.3389/fimmu.2022.816642
Subjects: REPARAÇÃO DE DNA; IMUNOTERAPIA; NEOPLASIAS; FARMACOTERAPIA
Keywords: DNA damage; PARP (poly(ADP-ribose); Cancer; Immune response; Immunotherapy; Polymerase
Agências de fomento:
- Financiamento Insper
- Financiamento FAPESP
Language: Inglês
Imprenta:
- Publisher place: Lausanne
- Date published: 2022
Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 13, art. 816642, p.1-10, 2022

Informações sobre o DOI: 10.3389/fimmu.2022.816642 (Fonte: oaDOI API)

Tipo	Nome	Link
	003153421.pdf	Direct link

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

WANDERLEY, Carlos Wagner de Souza et al. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications. Frontiers in Immunology, v. 13, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.816642. Acesso em: 29 dez. 2025.
APA

Wanderley, C. W. de S., Correa, T. S., Scaranti, M., Cunha, F. de Q., & Barroso-Sousa, R. (2022). Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications. Frontiers in Immunology, 13, 1-10. doi:10.3389/fimmu.2022.816642
NLM

Wanderley CW de S, Correa TS, Scaranti M, Cunha F de Q, Barroso-Sousa R. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2025 dez. 29 ] Available from: https://doi.org/10.3389/fimmu.2022.816642
Vancouver

Wanderley CW de S, Correa TS, Scaranti M, Cunha F de Q, Barroso-Sousa R. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2025 dez. 29 ] Available from: https://doi.org/10.3389/fimmu.2022.816642